Effects of differentiation status on apoptosis of human leukemia HL60 cells

Yaoxue Xuebao

Volumn 32, Issue 7, 1997, Pages 496-501

  Meng, F H ^a   He, Q Y ^a   Chi, X S ^b   Zhou, W D ^a   Zhang, H Q ^a   Xue, S B ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Apoptosis; c myc gene; Cell differentiation; Harringtonine; Human leukemia HL60 cell

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; HARRINGTONINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; DRUG EFFECT; HUMAN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CELL DIFFERENTIATION; HARRINGTONINES; HL-60 CELLS; HUMANS;

EID: 0031173320     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rovera G, Santoli D, Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diester. Proc Natl Acad Sci USA, 1979, 76:2779
2. Collins SJ, Ruscetti FW, Gallagher RE, et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc Natl Acad Sci USA, 1978, 75 :2458
3. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemic HL60 cell line by retinoic acid. Proc Natl Acad Sci USA, 1980, 77:2936
4. Solary E, Bertrand R, Kohn KW, et al. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood, 1993, 81:1359
5. Bino GD, Li X, Traganos F, et al. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Leukemia, 1994, 8:281
6. 3 protects HL60 cells against apoptosis but down-regulates the expression of bcl-2 gene. Exp Cell Res, 1993, 209:367
7. 4+ T cell blasts. Immunol Letters, 1993, 35:125
8. Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 1987, 70:1233
9. Lucas M, Sanchez-Margalet V. Protein kinase C involvement in apopotsis. Gen Pharmacol, 1995, 26:881
10. Frank DA, Sartorelli AC. Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cells. Biochem Biophy Res Commun, 1986, 140:440
11. Kuliczkowski K, Darley RL, Jacobs A, et al. Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPA. Leukemia Res, 1995, 19:291
12. Arends MJ, McGregor AH, Toft NJ, et al. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Haras oncogens and is associated with endonuclease availability. Br J Cancer, 1993, 68:1127
13. Park JR, Robertson K, Hickstein DD, et al. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood, 1994, 84:440
14. McCarthy JV, Fernandes RS, Gotter TG. Increased resistance to apoptosis associated with HL-60 myeloid differentiation status. Anticancer Res, 1994, 14:2063
15. Terui Y, Furukawa Y, Sakoe K, et al. Expression of differentiation-related phenotypes and apoptosis are independently regulated during myeloid cell differentiation. J Biochem, 1995, 117:77